Inventor · disambiguated record
Xueqing Wang
Also filed as: WANG XUEQING
41 granted patents·13 pending applications·347 citations·filing 2003–2022
97Inventor score
Top patents by PatentIndex Score
54 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0394US10138227B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2017·Granted Nov 27, 2018·31 cites·29 claims
- 0494US7875640B2Compounds as cannabinoid receptor ligandsABBOTT LAB·Filed 2008·Granted Jan 25, 2011·29 cites·28 claims
- 0593US7872033B2Compounds as cannabinoid receptor ligandsABBOTT LAB·Filed 2008·Granted Jan 18, 2011·26 cites·24 claims
- 0691US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0791US8501794B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted Aug 6, 2013·17 cites·7 claims
- 0890US8492371B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2010·Granted Jul 23, 2013·18 cites·17 claims
- 0990US8338467B2Compounds as cannabinoid receptor ligandsKOLASA TEODOZYJ·Filed 2011·Granted Dec 25, 2012·19 cites·13 claims
- 1090US8173687B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted May 8, 2012·18 cites·16 claims
- 1188US8288428B2Compounds as cannabinoid receptor ligandsWANG XUEQING·Filed 2010·Granted Oct 16, 2012·17 cites·13 claims
- 1288US8236822B2Compounds as cannabinoid receptor ligandsWANG XUEQING·Filed 2010·Granted Aug 7, 2012·17 cites·20 claims
- 1388US8058293B2Compounds as cannabinoid receptor ligandsKOLASA TEODOZYJ·Filed 2009·Granted Nov 15, 2011·17 cites·13 claims
- 1488US7528134B2Acetamides and benzamides that are useful in treating sexual dysfunctionABBOTT LAB·Filed 2003·Granted May 5, 2009·26 cites·9 claims
- 1586US10259810B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2017·Granted Apr 16, 2019·5 cites·8 claims
- 1684US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 1784US9890158B2N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2016·Granted Feb 13, 2018·5 cites·50 claims
- 1884US8481574B2Compounds as cannabinoid receptor ligandsMEYER MICHAEL D·Filed 2007·Granted Jul 9, 2013·17 cites·15 claims
- 1983US10954202B2Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2020·Granted Mar 23, 2021·1 cites·4 claims
- 2082US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 2181US9567322B2Substituted tetrahydropyrans and method of useABBVIE S Á R L·Filed 2015·Granted Feb 14, 2017·4 cites·98 claims
- 2279US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 2378US10604515B2Heteroaryl substituted pyridines and methods of useABBVIE SARL·Filed 2018·Granted Mar 31, 2020·1 cites·2 claims
- 2476US10647717B2N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of useABBVIE SARL·Filed 2019·Granted May 12, 2020·1 cites·3 claims
- 2573US9796711B2Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of useABBVIE S ÀR L·Filed 2016·Granted Oct 24, 2017·2 cites·42 claims
- 2672US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 2771US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 2871US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 2971US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 3069US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 3169US8895592B2Compounds as cannabinoid receptor ligandsFROST JENNIFER M·Filed 2009·Granted Nov 25, 2014·2 cites·12 claims
- 3263US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 3361US8859596B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted Oct 14, 2014·0 cites·9 claims
- 3461US8188135B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted May 29, 2012·0 cites·16 claims
- 3560US2017190693A1Substituted chromanes and method of useABBVIE S À R L·Filed 2017·Application pending·0 cites
- 3659US2019202823A1N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USEABBVIE SARL·Filed 2019·Application pending·0 cites
- 3757US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 3855US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 3955US2023019236A1Protein tyrosine phosphatase inhibitors and methods of use thereofCALICO LIFE SCIENCES LLC·Filed 2022·Application pending·0 cites
- 4053US8846730B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted Sep 30, 2014·0 cites·22 claims
- 4153US2019315687A1Substituted Pyrrolidines and Methods of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 4252US8841334B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2008·Granted Sep 23, 2014·0 cites·18 claims
- 4351US9193713B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2008·Granted Nov 24, 2015·0 cites·24 claims
- 4446US8835475B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2010·Granted Sep 16, 2014·0 cites·2 claims
- 4545US8865753B2Compounds as cannabinoid receptor ligandsKOLASA TEODOZYJ·Filed 2010·Granted Oct 21, 2014·0 cites·2 claims
- 4641US2006189639A1Antagonists of the mGlu receptor and uses thereofSTEWART ANDREW O·Filed 2006·Application pending·0 cites
- 4741US2005176727A1Oximes and hydrazones that are useful in treating sexual dysfunctionFiled 2004·Application pending·0 cites
- 4840US8906911B2Chemokine receptor antagonistsABBVIE INC·Filed 2013·Granted Dec 9, 2014·0 cites·21 claims
- 4940US2004029887A1Acetamides and benzamides that are useful in treating sexual dysfunctionFiled 2003·Application pending·0 cites
- 5040US2006009461A1Acetamides and benzamides that are useful in treating sexual dysfunctionBHATIA PRAMILA A·Filed 2005·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xueqing Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →